• SD-101 and Keytruda Combo Fights Head and Neck Tumors, Trial Shows
  • FDA Approves Opdivo-Yervoy Combo for Advanced Kidney Cancer
  • European Partnership Aims to Better Understand and Predict Immunotherapy Response
  • Immunotherapy Combo Boosts Survival in Mouse Models of Mesothelioma, Study Finds
  • First Stage of Bemcentinib-Keytruda Phase 2 Trial for Lung Cancer Completes Patient Enrollment
  • Keytruda Beats Chemo at Increasing NSCLC Patients’ Survival, Phase 3 Trial Shows
  • Society of Interventional Oncology and BTG Award Five Cancer Research Grants
  • Keytruda-Epacadostat Combo Fails Primary Goal in Phase 3 Trial for Melanoma, Companies Announce
  • Newly Developed Molecule Boosts Anti-cancer Immunity, Mouse Study Shows
  • Pfizer and Allogene Agree to Collaborate on Developing Donor-derived CAR T-cell Therapies
  • Five Prime Doses First Patient With Investigational Antibody FPA150
  • French, US Partners to Use Artificial Intelligence to Predict Cancer Treatment Response